Beijing Restricts Cold Drug Sales To Restrict Ephedrine Use
This article was originally published in PharmAsia News
Executive Summary
Beijing pharmacies are being used to crack down on illegal use of ephedrine by restricting the purchase of 30 types of common cold medicines containing the ingredient. The new local regulation restricts purchases to just five boxes or bottles per visit, enough for a week. China's State FDA notified pharmacies that police authorities were finding the ephedrine in the medicines was being used to make the recreational drug "ice" in some parts of the country. (Click here for more
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.